Kangbuk Samsung Hospital

• Efficacy and Safety of Enavogliflozin as an Add-on Therapy in Patients with Inadequately Controlled Type 2 Diabetes Mellitus and Obesity: Investigator-Initiated Trial

  Status unknown, 210 people, 14 Aug 2026

• NCT02933788

  Phase 4, Status unknown, 116 people, 14 Oct 2016

• NCT02191566

  Phase 2, Terminated, 8 people, 16 Jul 2014

• NCT02152306

  Collaborator, Phase 3, Completed, 143 people, 2 Jun 2014

• NCT00922480

  Collaborator, Phase 3, Completed, 506 people, 17 Jun 2009

• NCT00823550

  Collaborator, Phase 4, Status unknown, 462 people, 15 Jan 2009

Sources: trialsearch.who.int

• Role of Renal Biomarkers in Sarcopenia or Frailty in Patients With Liver Cirrhosis

  I22002, 3 Aug 2026

Sources: api.crossref.org